Transplant Skin Cancer Fellowship

The Transplant Skin Cancer Network is a multicenter initiative established to study skin cancer outcomes after solid organ transplantation. The study is led by the Department of Dermatology and Transplant Center at UCSF.

Transplant Skin Cancer Network Fellowships are available to postgraduates, medical students, residents, or research fellows who are interested in performing research under the supervision of network members.

View research grants from outside organizations.

Fellows will work with a mentor within the network and will participate in a multi-center, retrospective cohort study of skin cancer using data from transplant recipients’ medical

  1. The incidence of cutaneous squamous cell carcinoma, melanoma, and Merkel cell carcinoma in organ transplant recipients (OTR).
  2. The incidence of metastatic cutaneous squamous cell carcinoma, melanoma, and OTR.
  3. Rates of death from skin cancer in OTR.
  4. Association of outcomes with factors including: age; gender; type of transplant; history of prior skin cancer; duration of transplantation; geographic region; immunosuppressive regimen; frequency of dermatologic intervention.
Study population: All solid organ transplant patients receiving initial transplant between January 1, 2003 and December 31, 2003 and between January 1, 2008 and December 31, 2008.

Some fellows may be invited to participate in other activities of the network including:

  • Establishing a a registry of bio-specimens and techniques to aid in translational and basic science research collaborations related to skin cancer in organ transplant patients.
  • Publishing a series of case reports on complex cases in transplant skin cancer 
  • Conducting a Town Hall meeting of stakeholders with interest in the topic of skin cancer in transplant patients, including clinicians, researchers, the FDA, pharmaceutical representatives and patient advocate

Commitment, support, and recognition

Fellows will be expected to make a full time commitment to research for a period of about one year (but no less than four contiguous months), although residents and clinical fellows pursuing research for a one year period in combination with clinical duties will be considered on a case by case basis. At least one of a fellow’s designated research projects must be related to skin cancer in organ transplant patients. After the completion of the research period fellows will be required to submit a research summary, a letter of recommendation from their research mentor, and any papers published or in press.

This is a non-funded fellowship of the AAD and no financial support is being awarded. However, fellows may pursue and receive funding from other sources if they choose. A list of organizations offering funding for dermatology research is available in the awards, grants & scholarships section.

Approved fellows will be designated as being on the TCSN Fellowship Track until completion of the fellowship. Upon final approval by the Transplant Dermatology Research Fellowship Committee students will be designated as TSCN Fellows.
 

The fellowship is open to post-graduates, medical students, and research fellows who meet the following criteria:
  • Are able to commit between four months to one year to performing full time research in which a least one major project is related to skin cancer in organ transplant patients
  • Residents and clinical fellows pursing research for a one year period in combination with clinical duties will be considered on a case by case basis
  • Fellows must be mentored by a member of the Transplant Skin Cancer Network and applicants must be able to provide a letter or recommendation from their mentor along with their application. 
  • Submit description of planned or ongoing research. Preference will be given to applicants working on the Transplant Skin Cancer Incidence Study.

To apply for a Transplant Skin Cancer Network Fellowship, complete the online application, including providing the following information:

  •  Description of the transplant skin cancer-related research
  •   Letter of recommendation from Transplant Skin Cancer Network